The groups of markers were as follows: CD4+FoxP3+ (22) (women with GDM = 31, control = 27), CD4+CD127− (23, 25, 26) (GDM = 83, control = 93), and CD4+CD127−FoxP3+ (21, 22, 27) (women with GDM = 107, control = 116). This evidence concerns the gene CD4 and gestational diabetes.